Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ron J Keizer

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Computer Methods and Programs in Biomedicine|July 15, 2010
Piraña and PCluster: a modeling environment and cluster infrastructure for NONMEMRon J Keizer, Michel van Benten, Jos H Beijnen, et al.
The AAPS Journal|June 1, 2012
Performance of methods for handling missing categorical covariate data in population pharmacokinetic analysesRon J Keizer, Anthe S Zandvliet, Jos H Beijnen, et al.
Investigational New Drugs|June 1, 2011
Two-stage model-based design of cancer phase I dose escalation trials: evaluation using the phase I program of barasertib (AZD1152)Ron J Keizer, Anthe S Zandvliet, Jos H Beijnen, et al.
Therapeutic Drug Monitoring|May 17, 2024
Developing Parametric and Nonparametric Models for Model-Informed Precision Dosing: A Quality Improvement Effort in Vancomycin for Patients With ObesityMaria-Stephanie A Hughes, Jasmine H Hughes, Jeffrey Endicott, et al.
Clinical Pharmacology and Therapeutics|October 17, 2020
Continuous Learning in Model-Informed Precision Dosing: A Case Study in Pediatric Dosing of VancomycinJasmine H Hughes, Dominic M H Tong, Sarah Scarpace Lucas, et al.
Frontiers in Pharmacology|December 24, 2021
Population Pharmacokinetic Model Development of Tacrolimus in Pediatric and Young Adult Patients Undergoing Hematopoietic Cell TransplantationJordan T Brooks, Ron J Keizer, Janel R Long-Boyle, et al.
British Journal of Clinical Pharmacology|February 3, 2012
Model-based treatment optimization of a novel VEGFR inhibitorRon J Keizer, Anubha Gupta, Robert Shumaker, et al.
Cancer Chemotherapy and Pharmacology|March 3, 2012
Decitabine triphosphate levels in peripheral blood mononuclear cells from patients receiving prolonged low-dose decitabine administration: a pilot studyRobert S Jansen, Hilde Rosing, Pierre W Wijermans, et al.
Journal of Pharmaceutical Sciences|December 7, 2013
Development of an extended-release formulation of capecitabine making use of in vitro-in vivo correlation modellingJelte Meulenaar, Ron J Keizer, Jos H Beijnen, et al.
Frontiers in Pharmacology|July 28, 2020
Assessment of a Model-Informed Precision Dosing Platform Use in Routine Clinical Care for Personalized Busulfan Therapy in the Pediatric Hematopoietic Cell Transplantation (HCT) PopulationPraveen Shukla, Srijib Goswami, Ron J Keizer, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Computer Methods and Programs in Biomedicine|July 15, 2010
Piraña and PCluster: a modeling environment and cluster infrastructure for NONMEMRon J Keizer, Michel van Benten, Jos H Beijnen, et al.
The AAPS Journal|June 1, 2012
Performance of methods for handling missing categorical covariate data in population pharmacokinetic analysesRon J Keizer, Anthe S Zandvliet, Jos H Beijnen, et al.
Investigational New Drugs|June 1, 2011
Two-stage model-based design of cancer phase I dose escalation trials: evaluation using the phase I program of barasertib (AZD1152)Ron J Keizer, Anthe S Zandvliet, Jos H Beijnen, et al.
Therapeutic Drug Monitoring|May 17, 2024
Developing Parametric and Nonparametric Models for Model-Informed Precision Dosing: A Quality Improvement Effort in Vancomycin for Patients With ObesityMaria-Stephanie A Hughes, Jasmine H Hughes, Jeffrey Endicott, et al.
Clinical Pharmacology and Therapeutics|October 17, 2020
Continuous Learning in Model-Informed Precision Dosing: A Case Study in Pediatric Dosing of VancomycinJasmine H Hughes, Dominic M H Tong, Sarah Scarpace Lucas, et al.
Frontiers in Pharmacology|December 24, 2021
Population Pharmacokinetic Model Development of Tacrolimus in Pediatric and Young Adult Patients Undergoing Hematopoietic Cell TransplantationJordan T Brooks, Ron J Keizer, Janel R Long-Boyle, et al.
British Journal of Clinical Pharmacology|February 3, 2012
Model-based treatment optimization of a novel VEGFR inhibitorRon J Keizer, Anubha Gupta, Robert Shumaker, et al.
Cancer Chemotherapy and Pharmacology|March 3, 2012
Decitabine triphosphate levels in peripheral blood mononuclear cells from patients receiving prolonged low-dose decitabine administration: a pilot studyRobert S Jansen, Hilde Rosing, Pierre W Wijermans, et al.
Journal of Pharmaceutical Sciences|December 7, 2013
Development of an extended-release formulation of capecitabine making use of in vitro-in vivo correlation modellingJelte Meulenaar, Ron J Keizer, Jos H Beijnen, et al.
Frontiers in Pharmacology|July 28, 2020
Assessment of a Model-Informed Precision Dosing Platform Use in Routine Clinical Care for Personalized Busulfan Therapy in the Pediatric Hematopoietic Cell Transplantation (HCT) PopulationPraveen Shukla, Srijib Goswami, Ron J Keizer, et al.
Pageof 6